| RS121917722 |
PEPD
|
Health Risk |
Pathogenic |
Prolidase deficiency, Melanoma |
| RS121917723 |
PEPD
|
Health Risk |
Pathogenic/Likely pathogenic |
Prolidase deficiency, Prolidase deficiency |
| RS121917724 |
PEPD
|
Health Risk |
Pathogenic/Likely pathogenic |
Prolidase deficiency, Prolidase deficiency |
| RS121917725 |
PEPD
|
Health Risk |
Pathogenic |
Prolidase deficiency, Prolidase deficiency |
| RS121917731 |
MCC
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |
| RS121917732 |
MCC
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |
| RS121917734 |
EPB42
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 5, Hereditary spherocytosis type 5 |
| RS121917735 |
MAF
|
Health Risk |
Pathogenic |
Cataract 21 multiple types, Cataract 21 multiple types |
| RS121917736 |
MAF
|
Health Risk |
Pathogenic |
Cataract 21 multiple types, Cataract 21 multiple types |
| RS121917737 |
SFTPA2
|
Health Risk |
Pathogenic/Likely risk allele |
Interstitial lung disease 2, Pulmonary fibrosis |
| RS121917738 |
SFTPA2
|
Health Risk |
Pathogenic |
Interstitial lung disease 2, Interstitial lung disease 2 |
| RS121917739 |
RAD51
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer |
| RS121917740 |
REN
|
Health Risk |
Pathogenic |
HYPERPRORENINEMIA, FAMILIAL |
| RS121917741 |
REN
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal tubular dysgenesis, Familial juvenile hyperuricemic nephropathy type 2 |
| RS121917742 |
REN
|
Health Risk |
Pathogenic |
Renal tubular dysgenesis, Renal tubular dysgenesis |
| RS121917743 |
REN
|
Health Risk |
Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 2, Familial juvenile hyperuricemic nephropathy type 2 |
| RS121917744 |
RPE65
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 20, Leber congenital amaurosis 2 |
| RS121917745 |
RPE65
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 20, Leber congenital amaurosis 2 |
| RS121917746 |
SPR
|
Health Risk |
Pathogenic |
Dopa-responsive dystonia due to sepiapterin reductase deficiency, Dopa-responsive dystonia due to sepiapterin reductase deficiency |
| RS121917747 |
SPR
|
Health Risk |
Pathogenic |
Dopa-responsive dystonia due to sepiapterin reductase deficiency, Dystonic disorder |
| RS121917749 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS121917750 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS121917751 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS121917752 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial infantile |
| RS121917753 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial infantile |
| RS121917755 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma, Pheochromocytoma/paraganglioma syndrome 4 |
| RS121917756 |
HRAS
|
Health Risk |
Pathogenic |
Myopathy, congenital |
| RS121917757 |
HRAS
|
Health Risk |
Likely pathogenic |
Myopathy, congenital |
| RS121917758 |
HRAS
|
Health Risk |
Pathogenic |
Costello syndrome, HRAS-related disorder |
| RS121917759 |
HRAS
|
Health Risk |
Likely pathogenic |
Costello syndrome, Costello syndrome |
| RS121917760 |
TNNI3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, familial restrictive |
| RS121917761 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, familial restrictive |
| RS121917762 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS121917763 |
TH
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS121917764 |
TH
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS121917765 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS121917766 |
KDR
|
Health Risk |
Pathogenic |
Capillary infantile hemangioma, Capillary infantile hemangioma |
| RS121917767 |
UCHL1
|
Health Risk |
risk factor |
Parkinson disease 5, autosomal dominant |
| RS121917768 |
UMOD
|
Health Risk |
Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS121917769 |
UMOD
|
Health Risk |
Pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS121917770 |
UMOD
|
Health Risk |
Pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS121917771 |
UMOD
|
Health Risk |
Pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS121917772 |
UMOD
|
Health Risk |
Pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS121917773 |
UMOD
|
Health Risk |
Pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS121917774 |
UMOD
|
Health Risk |
Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS121917775 |
VIM
|
Health Risk |
Pathogenic |
Cataract 30, Cataract 30 |
| RS121917777 |
BBS1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome |
| RS121917778 |
BBS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome |
| RS121917780 |
HSD11B2
|
Health Risk |
Pathogenic |
Apparent mineralocorticoid excess, Apparent mineralocorticoid excess |
| RS121917781 |
HSD11B2
|
Health Risk |
Pathogenic |
Apparent mineralocorticoid excess, Apparent mineralocorticoid excess |
| RS121917782 |
HSD11B2
|
Health Risk |
Pathogenic |
Apparent mineralocorticoid excess, mild |
| RS121917783 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group C, Fanconi anemia |
| RS121917784 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group C, Fanconi anemia |
| RS121917785 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group C, Fanconi anemia complementation group C |
| RS121917786 |
FANCD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group D2, Inborn genetic diseases |
| RS121917787 |
FANCD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS121917788 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS121917789 |
MVK
|
Health Risk |
Pathogenic |
Mevalonic aciduria, Mevalonic aciduria |
| RS121917790 |
MVK
|
Health Risk |
Likely pathogenic |
Hyperimmunoglobulin D with periodic fever, Porokeratosis 3 |
| RS121917807 |
PSEN1
|
Health Risk |
Likely pathogenic |
Alzheimer disease, familial |
| RS121917808 |
PSEN1
|
Health Risk |
Pathogenic |
Alzheimer disease 3, Alzheimer disease 3 |
| RS121917809 |
PSEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1U, Primary dilated cardiomyopathy |
| RS121917812 |
CACNB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 4, Cardiovascular phenotype |
| RS121917814 |
AMACR
|
Health Risk |
Pathogenic/Likely pathogenic |
Alpha-methylacyl-CoA racemase deficiency, Congenital bile acid synthesis defect 4 |
| RS121917815 |
ADIPOQ
|
Health Risk |
Pathogenic |
Adiponectin deficiency, Adiponectin deficiency |
| RS121917816 |
AMACR
|
Health Risk |
Pathogenic |
Congenital bile acid synthesis defect 4, Congenital bile acid synthesis defect 4 |
| RS121917817 |
B4GALT7
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome progeroid type, Spondylodysplastic Ehlers-Danlos syndrome |
| RS121917818 |
B4GALT7
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome progeroid type, Ehlers-Danlos syndrome progeroid type |
| RS121917819 |
CDSN
|
Health Risk |
Pathogenic |
Hypotrichosis 2, Hypotrichosis 2 |
| RS121917820 |
CDSN
|
Health Risk |
Pathogenic |
Hypotrichosis 2, Hypotrichosis 2 |
| RS121917821 |
APOA5
|
Health Risk |
Pathogenic |
Familial type 5 hyperlipoproteinemia, Familial type 5 hyperlipoproteinemia |
| RS121917822 |
CHST6
|
Health Risk |
Pathogenic |
Macular corneal dystrophy, Macular corneal dystrophy |
| RS121917823 |
GJA3
|
Health Risk |
Likely pathogenic |
Cataract 14 multiple types, Cataract 14 multiple types |
| RS121917824 |
CHST6
|
Health Risk |
Conflicting classifications of pathogenicity |
Macular corneal dystrophy, Macular corneal dystrophy |
| RS121917825 |
GJA3
|
Health Risk |
Likely pathogenic |
Cataract 14 multiple types, Cataract 14 multiple types |
| RS121917827 |
GJA3
|
Health Risk |
Likely pathogenic |
Cataract 14 multiple types, Cataract 14 multiple types |
| RS121917828 |
CABP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod synaptic disorder, congenital nonprogressive |
| RS121917829 |
MC4R
|
Health Risk |
Pathogenic |
Obesity due to melanocortin 4 receptor deficiency, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 |
| RS121917830 |
EPOR
|
Health Risk |
Likely pathogenic |
Primary familial polycythemia due to EPO receptor mutation, Acute megakaryoblastic leukemia without down syndrome |
| RS121917832 |
CDKN1B
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 4, Multiple endocrine neoplasia type 4 |
| RS121917833 |
HSD11B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Apparent mineralocorticoid excess, Apparent mineralocorticoid excess |
| RS121917834 |
SFTPC
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS121917835 |
SFTPC
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS121917836 |
SFTPC
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS121917837 |
NEUROG3
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital malabsorptive diarrhea 4, NEUROG3-related disorder |
| RS121917838 |
NEUROG3
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital malabsorptive diarrhea 4, Congenital malabsorptive diarrhea 4 |
| RS121917839 |
PROP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pituitary hormone deficiency, combined |
| RS121917840 |
PROP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pituitary hormone deficiency, combined |
| RS121917841 |
PROP1
|
Health Risk |
Pathogenic |
Pituitary hormone deficiency, combined |
| RS121917842 |
PROP1
|
Health Risk |
Pathogenic |
Pituitary hormone deficiency, combined |
| RS121917843 |
PROP1
|
Health Risk |
Pathogenic |
Pituitary hormone deficiency, combined |
| RS121917844 |
PROP1
|
Health Risk |
Pathogenic |
Pituitary hormone deficiency, combined |
| RS121917845 |
PROP1
|
Health Risk |
Pathogenic |
Pituitary hormone deficiency, combined |
| RS121917846 |
SAR1B
|
Health Risk |
Pathogenic |
Chylomicron retention disease, Chylomicron retention disease |
| RS121917847 |
TRHR
|
Health Risk |
Pathogenic |
Hypothyroidism, congenital |
| RS121917849 |
TTPA
|
Health Risk |
Pathogenic/Likely pathogenic |
ATAXIA WITH ISOLATED VITAMIN E DEFICIENCY AND RETINITIS PIGMENTOSA, Familial isolated deficiency of vitamin E |
| RS121917850 |
TTPA
|
Health Risk |
Conflicting classifications of pathogenicity |
ATAXIA, FRIEDREICH-LIKE |
| RS121917851 |
TTPA
|
Health Risk |
Pathogenic |
ATAXIA, FRIEDREICH-LIKE |
| RS121917852 |
IHH
|
Health Risk |
Pathogenic |
Brachydactyly type A1, Brachydactyly type A1 |
| RS121917853 |
IHH
|
Health Risk |
Likely pathogenic |
Brachydactyly type A1, Brachydactyly type A1 |